HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO
A United Kingdom buyer, with 10 published contracts, worth £29.8m, most recently 9 months ago.
Top 5 suppliers won 100% of awarded value — £29.8m of £29.8m across 10 awards.
This contract involves the procurement of lyophilized tuberculosis vaccine (BCG) for the years 2025 to 2027. The buyer is the Croatian Institute of Public Health, and the total value of the contract is €78,000. Suppliers are invited to provide this essential health product to support public health i
This contract involves the procurement of a diphtheria and tetanus vaccine that is adsorbed and has a reduced antigen content. The procurement is intended for the years 2025 to 2027. Suppliers are invited to provide this vaccine to the Croatian Institute of Public Health, which is seeking to ensure
This contract opportunity is for the procurement of vaccines against Meningococcal Group B for the years 2025 to 2027. The buyer is the Croatian Institute of Public Health, and the total value of the contract is €76,220. Suppliers are invited to provide these essential vaccines to support public hea
This contract involves the procurement of combined vaccines for diphtheria, tetanus, pertussis (acellular), inactivated polio, Haemophilus influenzae type B, and hepatitis B. These vaccines are intended for primary vaccination and the first booster dose in the second year of life, covering the perio
This contract involves the procurement of rabies vaccines derived from cell cultures for human use, covering the period from 2025 to 2027. The total value of the contract is €1,051,200. The buyer is the Croatian Institute of Public Health, and the awarded supplier is MEDOKA d.o.o. Suppliers interest
This contract involves the storage and distribution of vaccines as part of the mandatory vaccination program and immunization initiatives for specific at-risk populations. The procurement is intended for the years 2025 to 2027. Suppliers are invited to provide services that ensure the safe and effic
The Croatian Public Health Institute is seeking suppliers for the procurement of diphtheria and tetanus vaccines with reduced antigen content for the years 2025 to 2027. This contract aims to ensure the availability of these essential vaccines to support public health initiatives. Interested supplie
This contract involves the procurement of a recombinant, adsorbed vaccine against human papillomavirus (HPV) for the years 2025 to 2027. The buyer is the Croatian Institute of Public Health, and the total value of the contract is approximately 9,207,900 euros. Suppliers interested in this opportunit
The Croatian Health Institute is seeking suppliers for the procurement of Palivizumab vaccines for the years 2025 to 2027. This contract is valued at approximately €7,248,690 and aims to ensure the availability of this important medication for public health. Interested suppliers should review the de
This contract opportunity is for the procurement of Hepatitis B vaccines (rDNA) intended for adolescents and adults. The procurement period spans from 2025 to 2027, with a total contract value of €273,000. Suppliers are invited to submit their bids by June 5, 2025. The buyer is the Croatian Institut
